Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gene Transfer Study of AAV9-CLN3 for Treatment NCL Type 3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03770572
Recruitment Status : Recruiting
First Posted : December 10, 2018
Last Update Posted : December 17, 2018
Sponsor:
Collaborator:
Amicus Therapeutics
Information provided by (Responsible Party):
Emily de los Reyes, Nationwide Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022
Publications: